论文部分内容阅读
依据20家三级甲等综合医院HIS数据库中的诊断信息及医嘱信息进行分析。采用频数分析及关联分析方法,结果显示炎症性肠病最常见的合并疾病依次为高血压病(2 058例,占13.94%)、慢性浅表性胃炎(1 611例,占10.92%)、肠良性肿瘤(1 351例,占9.51%)、冠心病(1 346例,占9.15%)、慢性胃炎(1 044例,占7.07%)、腹痛(1 030例,占6.98%)、慢性胃窦炎(988例,6.69%)、2型糖尿病(956例,6.48%)、上呼吸道感染(816例,5.53%)及消化道出血(784例,占5.31%)。蒙脱石散与黄连素片联合使用频率最高(35.56%),其次是复方甘草与氨溴索(29.8%),云南白药与血凝酶(28.8%),黄连素片与阿司匹林(27.91%)。研究提示炎症性肠病的合并疾病有其特点,应重视其合并疾病的治疗。同时,炎症性肠病的联合用药中医药占有相当比例,应注重中西药联合应用,以期达到理想的治疗效果。
Based on the diagnostic information and the doctor’s advice information in 20 Hospitals of Grade Three First Class General Hospital, Using frequency analysis and correlation analysis, the results showed that the most common diseases of inflammatory bowel disease were hypertension (2 058 cases, accounting for 13.94%), chronic superficial gastritis (1 611 cases, accounting for 10.92%), intestinal (351 cases, accounting for 9.51%), coronary heart disease (1146 cases, 9.15%), chronic gastritis (1044 cases, accounting for 7.07%), abdominal pain (1030 cases, accounting for 6.98%), chronic gastric antrum Inflammation (988 cases, 6.69%), type 2 diabetes (956 cases, 6.48%), upper respiratory tract infection (816 cases, 5.53%) and gastrointestinal bleeding (784 cases, accounting for 5.31%). Combination of montmorillonite and berberine tablets had the highest frequency (35.56%), followed by compound licorice and ambroxol (29.8%), Yunnanbaiyao and hemagglutinin (28.8%), berberine tablets and aspirin . Research suggests that inflammatory bowel disease has its own characteristics of the combined disease, should pay attention to the treatment of its combined diseases. At the same time, the combination of inflammatory bowel disease medicine occupies a considerable proportion of traditional Chinese and Western medicine should pay attention to the joint application, in order to achieve the desired effect of treatment.